Health
CHICAGO – Elevated blood pressure as young as age 18 is a warning sign of cardiovascular disease developing later in life and the time to begin prevention, according to a large national Northwestern Medicine study.
That's decades earlier than clinicians and patients generally start thinking about heart disease risk.
The study also found distinct blood pressure patterns from ages 18 to 55 that reveal people at high risk for calcification of coronary arteries – a marker for heart disease – by middle age.
Also known as hardening of the arteries, these calcium deposits can narrow coronary arteries and increase heart attack risk.
The 25-year study is the first to identify different long-term patterns of blood pressure levels and resulting cardiovascular risk.
“This shows that your blood pressure in young adulthood can impact your risk for heart disease later in life,” said Norrina Allen, lead study author and assistant professor of preventive medicine at Northwestern University Feinberg School of Medicine. “We can't wait until middle age to address it. If we can prevent their blood pressure from increasing earlier in life we can reduce their risk of future heart attacks and stroke.”
More than 33 percent of U.S. adults have hypertension. Currently, the clinical approach is to evaluate blood pressure risk in middle or older age and not consider how it may have changed or increased with age.
The paper will be published Feb. 4 in the Journal of the American Medical Association.
Tracking the long-term patterns in blood pressure starting in young adulthood will more accurately identify individuals at risk for heart disease. It also will enable earlier and more effective prevention, scientists said.
“If we see someone who is 25 or 30 and they fall into one of these patterns, we can predict where they'll be later in middle age,” Allen said. “Then we can prescribe lifestyle changes such as increased physical activity or a better diet that can prevent them from developing hypertension and a higher risk of disease.”
“In people with higher blood pressure, earlier intervention with lifestyle and with medication, when needed, is important,” noted senior author Donald Lloyd-Jones, M.D., chair of preventive medicine at Feinberg and a cardiologist at Northwestern Memorial Hospital. “Although blood pressure can be quickly lowered with medication, the damage to the heart and blood vessels that is caused by time spent with elevated blood pressure tends to remain. We can't put the horse all the way back in the barn.”
The study used data from 4,681 participants in the Coronary Artery Risk Development in Young Adults Study from baseline years 1985-1986 through 25 years of follow-up. The participants (black and white men and women) were 18 to 25 years old when the study began and from four urban sites including Chicago, Birmingham, Minneapolis, and Oakland.
The highest risk group had elevated blood pressure compared to their peers at age 18, but it was still within the range considered normal; this tended to develop into hypertension by middle age. They were four times more likely to have coronary artery calcification.
The study identified five patterns in blood pressure from young adulthood to middle age:
- 22 percent of participants maintained low blood pressure throughout follow-up (low-stable group);
- 42 percent had moderate levels (moderate-stable group);
- 12 percent started with moderate levels which increased at an average age of 35 years (moderate-increasing group);
- 19 percent had relatively elevated levels throughout (elevated-stable group);
- 5 percent started with elevated blood pressure, which increased during follow-up (elevated-increasing group).
Groups with elevated or increasing blood pressure were at the highest risk for developing calcification of coronary arteries.
The study also found African Americans and smokers were more likely to experience rapid increases in blood pressure during middle age, placing them at higher risk of heart disease.
- Details
- Written by: Editor
SAN FRANCISCO – This week the U.S. Environmental Protection Agency (EPA) announced over $3 million in grants to research institutions to better understand how chemicals interact with biological processes and how these interactions may lead to altered brain development.
The studies are focused on improving EPA’s ability to predict the potential health effects of chemical exposures.
The University of California, Davis (UC Davis) is one of the four grantees to receive $800,000 to conduct research on developmental neurotoxicity.
“This research will transform our understanding of how exposure to chemicals during sensitive lifestages affects the development of the brain,” said Lek Kadeli, acting assistant administrator for EPA’s Office of Research and Development. “By better predicting whether chemicals have the potential to impact health and human development, these grants will not only advance the science necessary to improve chemical safety but protect the well being and futures of children in this nation.”
From the project, UC Davis will conduct research to demonstrate how the thyroid hormone (TH), which is responsible for neurodevelopment, is affected by toxic chemicals.
Research will also provide insight into which parts of the neurodevelopment systems are susceptible to disruption, and improve assessments used to show impact to human health.
In addition to UC Davis, other recipients include: North Carolina State University in Raleigh, N.C., The University of Georgia in Athens, Ga., and the Sanford-Burnham Medical Research Institute in La Jolla, Calif.
These grants focus on developing better adverse outcome pathways (AOPs), which are models that predict the connection between exposures and the chain of events that lead to an unwanted health effect.
AOPs combine vast amounts of data from different sources to depict the complex interactions of chemicals with biological processes, and then extend this information to explain an adverse health effect.
EPA expects to use the knowledge gained from this research to develop efficient and cost-effective models to better predict if and how exposure to environmental chemicals may lead to developmental neurotoxicity.
These awards are advancing the science and technological capability to model and predict how chemicals behave when they come into contact with biological systems.
This improved understanding supports the agency’s mission of protecting human health and the environment and amplifies the impact of its chemical safety research efforts.
EPA’s chemical safety research is accelerating the pace of chemical screening, helping to protect vulnerable populations and species, developing solutions for more sustainable chemicals and using computational science to understand the relationship between chemical exposures and health outcomes.
For more information about these awards visit http://epa.gov/ncer/adversepath ,
For more information on EPA’s National Research Program on Chemical Safety, visit http://www.epa.gov/research/chemicalscience/ .
- Details
- Written by: Editor





How to resolve AdBlock issue?